NO20072642L - Use of androgens to reduce the likelihood of acquiring or to treat skin aging - Google Patents

Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Info

Publication number
NO20072642L
NO20072642L NO20072642A NO20072642A NO20072642L NO 20072642 L NO20072642 L NO 20072642L NO 20072642 A NO20072642 A NO 20072642A NO 20072642 A NO20072642 A NO 20072642A NO 20072642 L NO20072642 L NO 20072642L
Authority
NO
Norway
Prior art keywords
likelihood
acquiring
loss
androgens
reduce
Prior art date
Application number
NO20072642A
Other languages
English (en)
Norwegian (no)
Inventor
Fernand Labrie
Mohamed El-Alfy
Lamia Azzi
Original Assignee
Endorech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorech Inc filed Critical Endorech Inc
Publication of NO20072642L publication Critical patent/NO20072642L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NO20072642A 2004-11-01 2007-05-23 Use of androgens to reduce the likelihood of acquiring or to treat skin aging NO20072642L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62411204P 2004-11-01 2004-11-01
PCT/CA2005/001652 WO2006047859A1 (fr) 2004-11-01 2005-10-31 Utilisation d'androgenes pour retarder le vieillissement de la peau ou traiter celui-ci

Publications (1)

Publication Number Publication Date
NO20072642L true NO20072642L (no) 2007-07-30

Family

ID=36318842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072642A NO20072642L (no) 2004-11-01 2007-05-23 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Country Status (20)

Country Link
US (1) US20060178352A1 (fr)
EP (1) EP1807062A4 (fr)
JP (1) JP2008517952A (fr)
KR (1) KR20070073964A (fr)
CN (1) CN101094676A (fr)
AP (1) AP2007003982A0 (fr)
AU (1) AU2005301035A1 (fr)
BR (1) BRPI0517950A (fr)
CA (1) CA2585666A1 (fr)
EA (1) EA200700983A1 (fr)
GE (1) GEP20094833B (fr)
HR (1) HRP20070183A2 (fr)
IL (1) IL182844A0 (fr)
MA (1) MA29220B1 (fr)
MX (1) MX2007005098A (fr)
NO (1) NO20072642L (fr)
RS (1) RS20070185A (fr)
TN (1) TNSN07163A1 (fr)
WO (1) WO2006047859A1 (fr)
ZA (1) ZA200703531B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2749235C (fr) 2004-10-20 2014-08-12 Endorecherche, Inc. Precurseurs de steroide sexuel, seuls ou combines a un modulateur de recepteur d'oestrogene selectif et/ou a des oestrogenes et/ou a un inhibiteur de phosphodiesterase de type 5 cgmp, pour prevenir et traiter la secheresse vaginale et les dysfonctionnements sexuels chez la femme postmenopausee
CN101461294B (zh) 2006-06-01 2011-05-18 松下电器产业株式会社 洗衣机用无刷电动机以及搭载其的洗衣机
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
DE112014004733A5 (de) * 2013-10-15 2016-07-14 Chelac Holding Gmbh Steroid-Carbonsäureester, Zusammensetzungen, enthaltend Steroid-Carbonsäureester und Verwendung dieser bei lokal topischer Applikation für kosmetische oder dermatologische Zwecke
WO2017057743A1 (fr) * 2015-09-30 2017-04-06 富士フイルム株式会社 Composition absorbable par voie transdermique
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL88180C (fr) * 1953-08-26
SK286051B6 (sk) * 1993-01-19 2008-02-05 Endorecherche Inc. Použitie prekurzora pohlavného steroidu na prípravu liečiva na prevenciu alebo liečenie znížených alebo nevyrovnaných koncentrácií pohlavných steroidov
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
AR018660A1 (es) * 1998-06-11 2001-11-28 Endorech Inc Una composicion farmaceutica que comprende androst-5-en-3beta,17beta-diol o una prodroga del mismo; un kit y metodos terapeuticos que utilizan dicha composicion y un parche transdermico.
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy

Also Published As

Publication number Publication date
RS20070185A (en) 2008-09-29
JP2008517952A (ja) 2008-05-29
TNSN07163A1 (en) 2008-11-21
GEP20094833B (en) 2009-11-25
EA200700983A1 (ru) 2008-04-28
EP1807062A4 (fr) 2009-06-03
AU2005301035A1 (en) 2006-05-11
AP2007003982A0 (en) 2007-06-30
CN101094676A (zh) 2007-12-26
KR20070073964A (ko) 2007-07-10
HRP20070183A2 (en) 2007-08-31
BRPI0517950A (pt) 2008-10-21
EP1807062A1 (fr) 2007-07-18
US20060178352A1 (en) 2006-08-10
MX2007005098A (es) 2008-01-16
WO2006047859A1 (fr) 2006-05-11
IL182844A0 (en) 2007-09-20
MA29220B1 (fr) 2008-02-01
CA2585666A1 (fr) 2006-05-11
ZA200703531B (en) 2008-07-30

Similar Documents

Publication Publication Date Title
NO20072642L (no) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
WO2019004673A3 (fr) Composition anti-âge comprenant une vésicule extracellulaire dérivée de bactéries lactiques
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
DE502005001762D1 (de) Verwendung von N-Hydroxyalkyl-O-benzylchitosanen zur Haarbehandlung
DE60135755D1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
ATE500855T1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
WO2006073786A3 (fr) Compositions opthalmiques comprenant un steroide et une cyclosporine pour le traitement de l'oeil sec
EA201290698A1 (ru) Композиция, содержащая экстракт венериной мухоловки для косметической обработки
MX2011010781A (es) Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla.
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
AU2010300611A8 (en) Hematopoietic stem cells for use in the treatment of a kidney injury
WO2008070859A3 (fr) Traitement d'affections cutanées par dickkopf1 (dkk1)
Lou et al. Analysis of the effectiveness of basic fibroblast growth factor treatment on traumatic perforation of the tympanic membrane at different time points
DE502004008793D1 (fr)
PT1631275E (pt) Tratamento e prevenção da cicatrização excessiva com 4-hidroxi-tamoxifeno
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
ATE553760T1 (de) Verwendung von alverin zur behandlung von hauterkrankungen
UA88175C2 (ru) Способ косметической обработки стареющей кожи при помощи местного применения композиции, которая содержит циклогексанмоно-, -ди- или -триолы или циклогексилметан- или -этан-, или -пропанолы
US10874883B2 (en) Product for treating the skin and mucous membranes, and relative method of preparation
MXPA04011018A (es) Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
Truswell Combining fractional carbon-dioxide laser resurfacing with face-lift surgery
ATE483465T1 (de) Verwendung eines gleditsia-extrakts für kosmetik und dermatologie
WO2007142942A3 (fr) Méthode pour améliorer la cicatrisation d'une plaie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application